Yang Zhou

发表

Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-β-induced Pulmonary Fibrosis

Han-Oh Park, Won-Kyung Cho, J. Elias, 2012, The Journal of Biological Chemistry.

Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis

Won-Kyung Cho, J. Elias, C. Lee, 2014, The Korean journal of internal medicine.

Galectin-3 Interacts with the CHI3L1 Axis and Contributes to Hermansky–Pudlak Syndrome Lung Disease

Daniel S. Yang, W. Gahl, J. Elias, 2018, The Journal of Immunology.

Targeting Chitinase 1 and Chitinase 3-Like 1 as Novel Therapeutic Strategy of Pulmonary Fibrosis

B. Ma, C. Lee, J. A. Elias, 2022, Frontiers in Pharmacology.

Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis

T. Mustelin, D. Knight, C. Hogaboam, 2017, JCI insight.

Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra

A. Bryant, H. Karmouty-quintana, Yang Zhou, 2020, British journal of pharmacology.

Hermansky-Pudlak Syndrome and Lung Disease: Pathogenesis and Therapeutics

Yang Zhou, Dongqin Yang, E. Nakajima, 2021, Frontiers in Pharmacology.

Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema.

C. D. Dela Cruz, R. Homer, Won-Kyung Cho, 2011, American journal of respiratory cell and molecular biology.

Chitinase 3-like-1 and its receptors in Hermansky-Pudlak syndrome-associated lung disease.

W. Gahl, J. Elias, C. Lee, 2015, The Journal of clinical investigation.

Chitinase-like proteins in lung injury, repair, and metastasis.

B. Ma, R. Halaban, C. D. Dela Cruz, 2012, Proceedings of the American Thoracic Society.

Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19

B. Ma, C. Lee, J. A. Elias, 2022, eLife.

IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses

Y. Modis, B. Ma, C. D. Dela Cruz, 2016, Nature Communications.

Chitinase 1 Is a Biomarker for and Therapeutic Target in Scleroderma-Associated Interstitial Lung Disease That Augments TGF-β1 Signaling

S. Jimenez, J. Varga, C. Feghali-Bostwick, 2012, The Journal of Immunology.

Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension

G. Baird, C. Ventetuolo, C. Lee, 2022, JCI insight.

Induced Inflammation and Remodeling -Pattern/Influenza Virus and Cigarette Smoke Pathogen-Associated Molecular Role of Ribonuclease L in Viral

R. Silverman, B. Jha, Min-Jong Kang, 2013 .

Transforming growth factor β1 alters the 3′-UTR of mRNA to promote lung fibrosis

Leng Han, J. Elias, Yu Xiang, 2019, The Journal of Biological Chemistry.

Emerging Drug Delivery Strategies for Idiopathic Pulmonary Fibrosis Treatment.

Jyothi U. Menon, Yang Zhou, Dinesh Dhamecha, 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Suppression of NLRX1 in chronic obstructive pulmonary disease.

Bo Hye Kim, D. Boffa, J. Tedrow, 2015, The Journal of clinical investigation.

Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19

B. Ma, J. Machan, W. El-Deiry, 2021, JCI insight.

Chitinase 3-like-1 is a Therapeutic Target That Mediates the Effects of Aging in COVID-19

B. Ma, J. Machan, W. El-Deiry, 2021, bioRxiv.

Chitinase 3–Like 1 Suppresses Injury and Promotes Fibroproliferative Responses in Mammalian Lung Fibrosis

Buqu Hu, Jack A. Elias, Aditi Mathur, 2014, Science Translational Medicine.

Host Chitinase 3-like-1 is a Universal Therapeutic Target for SARS-CoV-2 Viral Variants in COVID 19

B. Ma, C. Lee, J. A. Elias, 2022, bioRxiv.

Chitinase 1 regulates pulmonary fibrosis by modulating TGF-β/SMAD7 pathway via TGFBRAP1 and FOXO3

B. Ma, A. Choi, I. Rosas, 2019, Life Science Alliance.

Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2

Y. Modis, B. Ma, C. D. Dela Cruz, 2013, Cell reports.

Plexin C1 deficiency permits synaptotagmin 7–mediated macrophage migration and enhances mammalian lung fibrosis

Naftali Kaminski, Buqu Hu, Jose D Herazo-Maya, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Role of Ribonuclease L in Viral Pathogen-Associated Molecular Pattern/Influenza Virus and Cigarette Smoke–Induced Inflammation and Remodeling

R. Silverman, B. Jha, J. Elias, 2013, The Journal of Immunology.

Suppression of NLRX 1 in chronic obstructive pulmonary disease

Bo Hye Kim, D. Boffa, J. Tedrow, 2022 .

Erratum to Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2, [Cell Reports 4, 2013, 830-841]

Y. Modis, B. Ma, L. Cantley, 2015 .

Scleroderma-Associated Interstitial Lung Therapeutic Target in Chitinase 1 Is a Biomarker for and

S. Jimenez, J. Varga, C. Feghali-Bostwick, 2017 .

Phospholipid scramblase-1 regulates innate type 2 inflammation in mouse lungs via CRTH2-dependent mechanisms

C. Lee, J. A. Elias, Yang Zhou, 2023, The Journal of clinical investigation.

CRTH2 Mediates Pro-fibrotic Macrophage Differentiation and Promotes Lung Fibrosis.

Thomas Walsh, B. Shea, Yang Zhou, 2022, American journal of respiratory cell and molecular biology.

Suppression of NLRX1 in chronic obstructive pulmonary disease.

Bo Hye Kim, D. Boffa, J. Tedrow, 2015, Journal of Clinical Investigation.

Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-β-induced Pulmonary Fibrosis

Han-Oh Park, Won-Kyung Cho, J. Elias, 2012, The Journal of Biological Chemistry.

Chitinase 3-like-1 is a therapeutic target that mediates the effects of aging in COVID-19

B. Ma, J. Machan, W. El-Deiry, 2021, JCI insight.

Corrigendum: IL-13Rα2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses

Y. Modis, B. Ma, J. Elias, 2016, Nature Communications.